微小RNA-210下调TET2并促进成年小鼠缺血性卒中后的神经炎症
研究在成年小鼠短暂性大脑中动脉闭塞模型中探索miR210通过抑制TET2调控缺血性卒中神经炎症的机制。结果显示miR210抑制通过TET2发挥抗神经炎症作用,提示miR210是缺血性卒中急性脑损伤的潜在治疗靶点。
要点
- miR210注射显著降低脑内TET2蛋白丰度,而miR210互补锁核酸或miR210敲除可保留TET2。
- TET2敲低逆转了miR210抑制或miR210敲除对脑梗死体积和神经行为缺陷的保护作用。
- TET2敲低削弱了miR210抑制对小胶质细胞激活和IL-6释放的抗炎效应。
核心结论
- 在成年小鼠脑内,抑制miR210通过抑制TET2减少缺血性卒中诱导的神经炎症反应,提示miR210是缺血性卒中后急性脑损伤的潜在治疗靶点。
研究设计与样本
- 在成年野生型或miR210敲除小鼠中通过短暂性腔内大脑中动脉闭塞诱导缺血性卒中。
- 使用TET2沉默RNA、miR210互补锁核酸寡核苷酸注射或miR210敲除小鼠验证miR210-TET2轴及其在缺血性脑损伤中的作用。
- 在BV2小胶质细胞中检测TET2过表达对miR210刺激的促炎细胞因子的影响。
- 检测包括磁共振成像扫描脑梗死体积、神经行为测试、逆转录定量聚合酶链反应和Western blot检测miR210及TET2水平、流式细胞术和ELISA检测卒中后脑内或体外小胶质细胞的神经炎症。
主要发现
- miR210注射显著降低脑内TET2蛋白丰度,而miR210互补锁核酸寡核苷酸或miR210敲除无论有无缺血性脑损伤均保留TET2。
- TET2敲低逆转了miR210抑制或miR210敲除对缺血性卒中诱导的脑梗死体积和神经行为缺陷的保护效应。
- 流式细胞术和ELISA显示,TET2敲低还显著削弱了miR210抑制对卒中后小胶质细胞激活和IL-6释放的抗炎效应。
- 在BV2小胶质细胞中,TET2过表达抵消了miR210诱导的细胞因子增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke is a leading cause of morbidity and mortality worldwide. Neuroinflammation plays a key role in acute brain injury of ischemic stroke. MicroRNA-210 (miR210) is the master hypoxamir and regulates microglial activation and inflammation in a variety of diseases. In this study, we uncovered the mechanism of miR210 in orchestrating ischemic stroke-induced neuroinflammation through repression of TET2 (ten-eleven translocation methylcytosine dioxygenase 2) in the adult mouse brain. METHODS: Ischemic stroke was induced in adult WT (wild type) or miR210 KO (miR210 deficient) mice by transient intraluminal middle cerebral artery occlusion. Injection of TET2 silencing RNA or miR210 complementary locked nucleic acid oligonucleotides, or miR210 KO mice were used to validate miR210-TET2 axis and its role in ischemic brain injury. Furthermore, the effect of TET2 overexpression on miR210-stimulated proinflammatory cytokines was examined in BV2 microglia. Post assays included magnetic resonance imaging scan for brain infarct size; neurobehavioral tests, reverse transcription-quantitative polymerase chain reaction, and Western blot for miR210; and TET2 levels, flow cytometry, and ELISA for neuroinflammation in the brain after stroke or microglia in vitro. RESULTS: miR210 injection significantly reduced TET2 protein abundance in the brain, while miR210 complementary locked nucleic acid oligonucleotides or miR210 KO preserved TET2 regardless of ischemic brain injury. TET2 knockdown reversed the protective effects of miR210 inhibition or miR210 KO on ischemic stroke-induced brain infarct size and neurobehavioral deficits. Moreover, flow cytometry and ELISA assays showed that TET2 knockdown also significantly dampened the anti-inflammatory effect of miR210 inhibition on microglial activation and IL (interleukin)-6 release after stroke. In addition, overexpression of TET2 in BV2 microglia counteracted miR210-induced increase in cytokines. CONCLUSIONS: miR210 inhibition reduced ischemic stroke-induced neuroinflammatory response via repression of TET2 in the adult mouse brain, suggesting that miR210 is a potential treatment target for acute brain injury after ischemic stroke.
引用
- Li Y, Song R, Shen G, et al. MicroRNA-210 Downregulates TET2 (Ten-Eleven Translocation Methylcytosine Dioxygenase 2) and Contributes to Neuroinflammation in Ischemic Stroke of Adult Mice. Stroke. 2023. PMID: 36734233. doi:10.1161/STROKEAHA.122.041651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。